Hologic Inc Net Income per Employee (HOLX), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Hologic Inc  (NASDAQ: HOLX)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Hologic Inc Net Income per Employee

HOLX's Quarterly Results, Trends, Rankings, Statistics
Hologic Inc's Income per employee fell in the first quarter 2026 on a trailing twelve month basis to $ 76,917, below the company average number of $78,616.
The Healthcare sector has seen employees of 4 other companies achieving higher income per employee. While Hologic Inc's total ranking has deteriorated compared to the previous quarter from 1032 to 1257.


What is Income per Employee Ratio?






HOLX Net Income per Employee (Dec 27 2025)
I. Quarter
(Sep 27 2025)
IV. Quarter
(Jun 28 2025)
III. Quarter
(Mar 29 2025)
II. Quarter
(Dec 28 2024)
I. Quarter
Y / Y Net Income Change -10.9 % 4.82 % 0.21 % - -18.46 %
Net Income per Employee (TTM) $ 76,917 80,014 78,798 78,741 105,233
HOLX's Total Ranking # 1257 # 1032 # 911 # 956 # 419
Seq. Net Income Change -4.33 % -3.95 % - - 12.54 %


HOLX Net Income per Employee Company Ranking
Within: No.
Medical Laboratories Industry # 5
Healthcare Sector # 115
Overall Market # 1257

Net Income per Employee Statistics
High Average Low
$ 288,685 $ 78,616 $ -59,321
(Jun 26 2021)   (Dec 29 2018)







Companies with similar Income per Employee for 12 month ending Dec 27 2025, within Healthcare Sector Income per Employee Income 12 month ending Dec 27 2025Number of Employees Dec 27 2025
Corcept Therapeutics Inc  134,480.82 $ 98.171  Million 730 
Resmed Inc   130,683.82 $ 1,485.875  Million 11,370 
Carlisle Companies Incorporated  125,542.37 $ 740.700  Million 5,900 
Alnylam Pharmaceuticals Inc   125,498.80 $ 313.747  Million 2,500 
Astrazeneca Plc  123,140.79 $ 10,233.000  Million 83,100 
Alkermes Plc   117,884.88 $ 241.664  Million 2,050 
Soleno Therapeutics Inc  114,780.22 $ 20.890  Million 182 
Inspire Medical Systems inc   109,093.77 $ 145.422  Million 1,333 
Check Cap Ltd  108,947.37 $ 4.140  Million 38 
Biomarin Pharmaceutical Inc  108,320.71 $ 348.901  Million 3,221 
Pfizer Inc  104,160.00 $ 7,812.000  Million 75,000 
Bio rad Laboratories Inc   102,000.00 $ 759.900  Million 7,450 
Idexx Laboratories Inc  96,314.91 $ 1,059.464  Million 11,000 
Cryoport inc   95,258.81 $ 70.301  Million 738 
Globus Medical Inc   89,644.67 $ 537.868  Million 6,000 
Lemaitre Vascular Inc   88,143.51 $ 57.734  Million 655 
Veracyte Inc   87,884.77 $ 66.353  Million 755 
Seres Therapeutics Inc   86,303.03 $ 5.696  Million 66 
Psyence Biomedical ltd   84,315.83 $ 1.012  Million 12 
Waters Corporation  81,345.44 $ 642.629  Million 7,900 
Ani Pharmaceuticals Inc  80,759.79 $ 78.337  Million 970 
Solventum Corporation  77,800.00 $ 1,556.000  Million 20,000 
Hologic Inc  76,916.55 $ 543.800  Million 7,070 
Embecta Corp   75,405.41 $ 139.500  Million 1,850 
Dexcom Inc   75,342.34 $ 836.300  Million 11,100 
Qiagen N v   74,540.35 $ 424.880  Million 5,700 
Abbvie Inc   74,263.16 $ 4,233.000  Million 57,000 
Medpace Holdings Inc   72,761.77 $ 451.123  Million 6,200 
Agilent Technologies inc   71,270.72 $ 1,290.000  Million 18,100 
Strata Critical Medical Inc   68,797.00 $ 41.347  Million 601 


Date modified: 2026-09-08T18:07:07+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.